MedTrace Logo

Surgical Treatment of Pelvis in Fragility Fracture in Germany: a Prospective, National, Multicenter, Observational, Comparative Cohort Study Comparing Isolated Posterior Versus Combined Anterior-posterior Surgical Fracture Stabilization

NCT06550934 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 420

Last updated 2025-02-14

No results posted yet for this study

Summary

Over a period of approximately two years, patients above the age of 65 who have suffered from an FFP equal to or higher than type IIc FFP, according to Rommens and Hofmann, will be eligible for inclusion. At least 420 patients will be included and followed up up for 12 months. Treatment and postoperative care, will be as per standard of care at the participating institution, with a free choice of isolated posterior or combined anterior-posterior surgical treatment.

Pain levels, quality of life, level of mobility and independence will be assessed at different time points. Furthermore, both clinical and radiographic outcomes, complications, morbidity and mortality associated with interventions will be evaluated. Assessment and evaluation will be performed at defined time points during FU according to standard of care.

Conditions

  • Pelvis; Fracture

Interventions

PROCEDURE

Fracture stabilization

isolated posterior surgical fracture stabilization vs. combined anterior-posterior surgical fracture stabilization

Sponsors & Collaborators

  • AUC - Akademie der Unfallchirurgie

    collaborator UNKNOWN

  • AO Trauma Deutschland e.V.

    collaborator OTHER

  • AO Innovation Translation Center

    lead OTHER

Principal Investigators

  • Richard Stange, Prof · Universitätsklinikum Münster

  • Lars Grossterlinden, Prof · Asklepios Klinik Altona, Hamburg

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-31
Primary Completion
2026-10-31
Completion
2027-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06550934 on ClinicalTrials.gov